Korean Patent Linkage Scheme Sees First Winners, Losers
This article was originally published in PharmAsia News
An increasing number of South Korean generic manufacturers are benefiting from a “first generic” system introduced under a drug patent-approval linkage system implemented in March. The Ministry of Food and Drug Safety has so far approved 54 preparations of three original drugs as first generics, which gives the products nine months of marketing exclusivity.
Register for our free email digests: